157 related articles for article (PubMed ID: 30052418)
21. Aging, Cellular Senescence, and Alzheimer's Disease.
Liu RM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216123
[TBL] [Abstract][Full Text] [Related]
22. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.
Peters DG; Pollack AN; Cheng KC; Sun D; Saido T; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
Metallomics; 2018 Mar; 10(3):426-443. PubMed ID: 29424844
[TBL] [Abstract][Full Text] [Related]
23. Effect of Inflammatory Mediators Lipopolysaccharide and Lipoteichoic Acid on Iron Metabolism of Differentiated SH-SY5Y Cells Alters in the Presence of BV-2 Microglia.
Pandur E; Varga E; Tamási K; Pap R; Nagy J; Sipos K
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577543
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and functional differences between senescent and aged murine microglia.
Stojiljkovic MR; Ain Q; Bondeva T; Heller R; Schmeer C; Witte OW
Neurobiol Aging; 2019 Feb; 74():56-69. PubMed ID: 30439594
[TBL] [Abstract][Full Text] [Related]
25. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.
Liu YL; Chen WT; Lin YY; Lu PH; Hsieh SL; Cheng IH
Mol Neurodegener; 2017 Apr; 12(1):30. PubMed ID: 28438208
[TBL] [Abstract][Full Text] [Related]
26. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
27. Krüppel-like factor 4 regulates amyloid-β (Aβ)-induced neuroinflammation in Alzheimer's disease.
Li L; Zi X; Hou D; Tu Q
Neurosci Lett; 2017 Mar; 643():131-137. PubMed ID: 28189744
[TBL] [Abstract][Full Text] [Related]
28. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
29. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
[TBL] [Abstract][Full Text] [Related]
30. Effects of senescence and angiotensin II on expression and processing of amyloid precursor protein in human cerebral microvascular endothelial cells.
Sun R; He T; Pan Y; Katusic ZS
Aging (Albany NY); 2018 Jan; 10(1):100-114. PubMed ID: 29348391
[TBL] [Abstract][Full Text] [Related]
31. Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.
Marwarha G; Rostad S; Lilek J; Kleinjan M; Schommer J; Ghribi O
J Alzheimers Dis; 2017; 57(3):907-925. PubMed ID: 28304295
[TBL] [Abstract][Full Text] [Related]
32. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
[TBL] [Abstract][Full Text] [Related]
33. BAY 11-7082 inhibits the secretion of interleukin-6 by senescent human microglia.
Cook M; Lin H; Mishra SK; Wang GY
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):30-35. PubMed ID: 35671608
[TBL] [Abstract][Full Text] [Related]
34. Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells.
Kraus B; Wolff H; Heilmann J; Elstner EF
Life Sci; 2007 Aug; 81(11):884-94. PubMed ID: 17725929
[TBL] [Abstract][Full Text] [Related]
35. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
[TBL] [Abstract][Full Text] [Related]
36. A cell model for the initial phase of sporadic Alzheimer's disease.
Stockburger C; Gold VA; Pallas T; Kolesova N; Miano D; Leuner K; Müller WE
J Alzheimers Dis; 2014; 42(2):395-411. PubMed ID: 24898661
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-β by targeting insulin-like growth factor 1 in microglia.
Xing H; Guo S; Zhang Y; Zheng Z; Wang H
Mol Med Rep; 2016 Aug; 14(2):1357-64. PubMed ID: 27277332
[TBL] [Abstract][Full Text] [Related]
38. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.
Tan J; Town T; Mori T; Wu Y; Saxe M; Crawford F; Mullan M
J Neurosci; 2000 Oct; 20(20):7587-94. PubMed ID: 11027218
[TBL] [Abstract][Full Text] [Related]
39. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
40. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
